I
schemic injury to the myocardium triggers a robust inflammatory response that is an integral part of the healing process and vital to maintenance of tissue integrity, preservation of contractile function, and optimal clinical outcomes. 1 This cascade of inflammatory events involves an initial destructive phase that serves to clear dead tissue. This, in turn, sets the stage for a subsequent repair phase that promotes myocardial healing. 2, 3 Although crucial to the repair process, the initial inflammatory response is closely associated with infarct expansion, myocardial rupture, and adverse remodeling in preclinical models 4 and in patients with acute coronary syndromes. [5] [6] [7] Although much effort has been directed at tempering the inflammatory response in hopes of achieving clinical gain, results from clinical trials have disappointed. 8 To date, major efforts have focused on individual cytokines such as tumor necrosis factor-α (TNFα) and interleukin-1β (IL1β), the complement cascade, and antibodies to adhesion molecules preventing leukocyte invasion (reviewed elsewhere 9 ). Macrophages are protagonists of both the inflammatory phase and the repair phase after tissue injury. 1 Initially, inflammatory monocytes/macrophages (Ly6C hi subtypes, M1-like macrophages) predominate within the infarct area. 10, 11 They elicit cytotoxic effector molecules such as reactive oxygen species and nitric oxide, generate inflammatory cytokines such as TNFα and IL1β, 12 and manifest avid phagocytic activity, thereby facilitating elimination of damaged myocardium and setting the stage for tissue repair. Subsequently, these Ly6C hi macrophages transform into a Ly6C lo subtype (reparative, M2-like macrophages) that fosters repair by promoting the deposition of extracellular matrix proteins and angiogenesis and dampening inflammation through anti-inflammatory cytokines. 10, 12 Suppression of this phenotypic transformation from destructive macrophages to reparative ones, as well as depletion of reparative macrophages, results in inefficient repair 13 and catastrophic outcomes after myocardial infarction (MI). 14 The ability of macrophages to adopt a variety of functional phenotypes driven by subtle changes in microenvironmental cues makes them potential targets in modulating the inflammation process. In patients with an acute coronary syndrome, a dramatic spike in metabolic activity in the spleen likely reflects enhanced production of new monocytes that are ultimately recruited to the ischemic region 15 and are predictive of future events. 16 Indeed, there is interest in targeting the macrophage transformation process to promote tissue repair and limit inflammation. However, better understanding of the environmental triggers and molecular networks regulating the switch of macrophage phenotype is required.
Damage to the myocardium resulting in cell injury and necrosis triggers both passive and active release of a variety of substances called danger-associated molecular patterns (DAMPs). 17 These substances include proteins or protein fragments, small molecules, and RNA. These DAMPs, in turn, activate inflammatory mediators by binding to pattern recognition receptors (PRRs). 17 Although a number of DAMPs and PRRs have been identified as playing a role in the inflammatory response after MI, 3 their roles in modulating macrophage function after ischemic injury remain poorly defined.
One possible but heretofore unexplored DAMP in myocardial injury is the DNA released by necrotic myocardium. We postulated that this cytosolic DNA is sensed by the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon (IFN) genes (STING) cascade, which thereby functions as a PRR in this context. 18 We go on to define the inflammatory events occurring downstream of this biology.
METHODS
All data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing our results or replicating the procedures. Detailed methods are provided in the online-only Data Supplement.
Animals
Animals were maintained in a pathogen-free environment with free access to food and water. They were maintained on a 12-hour light/dark cycle from 6 am to 6 pm. All procedures were approved by the Institutional Animal Care and Use Committee at the University of Texas Southwestern Medical Center.
Statistical Analyses
Findings are expressed as mean±SD. The data were analyzed with statistical software (GraphPad Prism, version 7.01;
Clinical Perspective
What Is New?
• We report that release of DNA from necrotic tissue during myocardial infarction triggers in macrophages a recently described innate immune response.
• This response, in turn, promotes an inflammatory macrophage phenotype.
• Suppression of the pathway promotes the emergence of reparative macrophages, thereby mitigating pathological ventricular remodeling.
What Are the Clinical Implications?
• These results reveal that a cytosolic DNA receptor functions during cardiac ischemia as a pattern recognition receptor in the sterile immune response.
• Because modulators of this pathway are currently in clinical use, our findings raise the prospect of new treatment options to combat ischemic heart disease and its progression to heart failure.
By sensing the presence of cytosolic DNA, the recently described cGAS-STING pathway plays a central role in the defense against microbial invasions. 18-21 After binding to cytosolic DNA, cGAS synthesizes a noncanonical second messenger, cyclic GAMP-AMP (cGAMP). cGAMP, in turn, activates STING, which then leads to the activation of IFN regulatory factor 3 (IRF3), 22 which triggers expression of type 1 IFN and IFN-stimulated genes (ISGs). IRF3 activates the core transcriptional programs induced by the prototypical stimulators of inflammatory macrophages, lipopolysaccharide and IFNγ, 23, 24 serving to maintain their inflammatory activity.
Although massive cell death, with consequent release of both nuclear and mitochondrial DNA, is a central event in MI, whether this pathway participates in the resulting inflammatory response is unknown. To explore this, we began by assessing for activity of the cGAS-STING pathway after MI. Triggering of this pathway is gauged by transcriptional activation of a group of ISGs. 20, [25] [26] [27] [28] ISGs are effector molecules of IFNs and are responsible for their antiviral, antiproliferative, and immunomodulatory effects.
We induced MI by surgical ligation of the left anterior descending coronary artery and collected samples at 3 and 7 days after the procedure. Using quantitative polymerase chain reaction assays, we evaluated the abundance of transcripts coding for IFN-regulatory factor 7 (IRF7), IFN-induced protein with tetratricopeptide repeat 1 (IFIT1), IFIT3, and C-X-C motif chemokine 10 (CXCL10), all established to be transcriptional targets of cGAS-STING. 20, [25] [26] [27] [28] We observed consistent and significant increases in CXCL10, IFIT1, IFIT3, and IRF7 in mice after MI compared with sham-operated controls ( Figure 1A-1D) . Upregulation of these markers occurred predominantly in the infarct zone and reached peak levels 7 days after coronary artery ligation. Consistent with the consensus in the literature that these are markers of cGAS activation, increases in these ISGs were not observed in cGAS −/− mice subjected to MI ( Figure 1A-1D ). Comparable findings were observed in bone marrow-derived macrophages (BMDMs) ( Figure I in the online-only Data Supplement). CD14, a macrophage surface receptor recognizing low-density lipoprotein and implicated in atherogenesis in humans [29] [30] [31] that has not been recognized as a target of cGAS activation, was also increased in wild-type (WT) mice subjected to MI but not in cGAS-null mice ( Figure 1E ), suggesting that CD14 is under the control of this pathway as well.
In addition to detecting evidence of cGAS-STING pathway activation, we observed significant increases in the abundance of transcripts coding for the pathway effectors themselves ( Figure 1F and 1G) . Upregulation of STING was further confirmed at the protein level ( Figure 1H and 1I), with increases occurring at a much lower magnitude in cGAS-null mice. Together, these findings point to cGAS-STING pathway activation in MI.
cGAS-Mediated Cytosolic DNA Sensing During MI Does Not Affect Expression of Major Inflammatory Cytokines
To begin to define effects of cGAS-mediated DNA sensing in MI, we first tested for changes in cytokine levels. The canonical molecular circuitry of cGAS-mediated DNA sensing is production of type I IFNs (IFNα and IFNβ), which are prototypical cytokines inducing inflammation in the setting of viral infection. In the context of myocardial ischemia, IL1, especially IL1β, is markedly induced and often linked to worse outcomes by promoting inflammation, remodeling, and heart failure. 4, 32, 33 That said, whereas pharmacological blockade of IL1β has met with recent success in atherosclerotic disease, 34 in the context of myocardial remodeling from ischemic stress, this strategy has garnered mixed results. 32, 35, 36 We observed that ischemic injury induced IL1β expression in the infarct region, as expected; however, inactivation of cGAS did not alter IL1β transcript levels ( Figure 2A) .
We next evaluated the inflammasome pathway, which is responsible for generating active IL1β. Again, we observed no differences between WT and cGAS −/− mice in the transcript levels of caspase 1, IL18, and Nlrp3 (Figure 2B-2D ). Furthermore, loss of cGAS-mediated signaling did not alter TNFα and IL6 ( Figure 2E and 2F). Together, these results indicate that activation of the cGAS-STING pathway does not affect the major proinflammatory cytokines at the level of transcript abundance.
Cytosolic DNA-Induced Expression of M1 Markers Inducible Nitric Oxide Synthase and CXCL10 Are cGAS-Dependent
We next turned our attention to macrophages. First, macrophages invade an MI early, emerging as the majority cell type during and throughout the early phase of repair and peaking at ≈day 6. 37 Our data pointing to activation of the cGAS-STING pathway ( Figure 1 ) correlate largely with this time course. Furthermore, macrophages harbor robust DNA-sensing activity. 20 Second, it is well established that M1-like macrophages are proinflammatory and antimicrobial; M2-like macrophages (also referred to as reparative macrophages), on the other hand, are pro-wound heal- 
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ing, profibrotic, and anti-inflammatory. 38 Furthermore, ISGs under the control of cGAS (Figure 1 ) are among the most highly downregulated genes during macrophage polarization from M1-like to M2-like macrophages. 39 This, coupled with the established phagocytic nature of macrophages targeting damaged myocardium, 10, 40 suggested to us that cGAS-STING pathway activation may play a role in the transition of macrophage pools from an activated/ inflammatory (M1-like) subtype to the activated/reparative (M2-like) subtype. To test this hypothesis, we harvested BMDMs and evaluated their M1-like versus M2-like phenotype after they were challenged with DNA.
First, we evaluated the induction of inducible nitric oxide synthase (iNOS) and the expression of arginase 1 (Arg1). Nitric oxide mediates the cytotoxic effects of macrophages, and induction of iNOS is a signature of inflammatory macrophages. 41 Arg1 shares, and thus competes for, the same substrate (l-arginine) as iNOS. Arg1 metabolizes l-arginine into ornithine and proline, the latter being critical for the synthesis of collagen. 42 The macrophage dichotomy (M1-like versus M2-like) originates in part from the divergent expression of iNOS and Arg1. 43, 44 Therefore, the ratio of iNOS to Arg1 is a classic readout in characterizing inflammatory versus reparative macrophages.
Transfection of IFN stimulatory DNA (ISD) into WT BMDMs resulted in a clear increase in TANK (TRAF [TNF receptor (TNFR) associated factor] Family Member Associated NFKB Activator)-binding kinase 1 phosphorylation (an established downstream element within the cGAS-STING pathway) by 6 hours that persisted for 18 hours ( Figure 3A and 3B) . 45 As expected, this pathway was not activated in cells lacking cGAS ( Figure 3A and 3B). Examination of Arg1 protein levels revealed no significant difference in the presence or absence of either ISD stimulation or cGAS ablation ( Figure 3A and 3E) . Conversely, ISD treatment resulted in a significant increase in iNOS levels only in WT cells ( Figure 3A and 3C). Similarly, induction of CXCL10 by ISD depended on the presence of cGAS ( Figure 3A and 3D) . Finally, the anti-inflammatory cytokines IL4 and TGFβ, which can counteract M1-like macrophage activation, 46 reduced the levels of iNOS and CXCL10. Furthermore, cGAS-null macrophages expressed higher levels of early growth response protein 2 (Egr2), fibronectin (Fn), and TGFβ ( Figure 3F ), all of which participate in the molecular signature of M2-like macrophages. 39 In addition, DNA stimulation induced CD38 expression exclusively in WT BMDMs ( Figure 3G ). Because Egr2 and CD38 are the most effective markers differentiating M1-like and M2-like macrophages, 39 these results lend further credence to a role for cGAS in the activation of inflammatory (M1-like) programs in macrophages.
cGAS Is Not Required for the Inflammatory Response Elicited by Lipopolysaccharide and IFNγ
The inability of the cGAS-null BMDMs to respond to ISD could be the result of a global defect in monocyte/macrophage differentiation or a defect in their activation. Because macrophages respond to a number of inflammatory signals, including LPS and the cytokine IFNγ, we next examined the impact of cGAS-mediated signaling in response to these polarizing agents. BMDMs were treated with either LPS or IFNγ, and induction of the inflammatory response was measured. Unlike treatment with ISD, treatment with LPS and IFNγ elicited robust iNOS and CXCL10 induction in both the WT and cGAS-null cells ( Figure 3H and 3I). Similarly, a strong increase was noted in the mRNA levels of inflammatory cytokines, including IL1β, IL1α, and IL6, in both WT and cGAS-null macrophages ( Figure 3J ). In addition, ISGs such as IFIT1, IFIT3, and IRF7 were induced by LPS and IFNγ similarly in WT and cGAS-null macrophages ( Figure 3K ). These data suggest that cGAS represents a novel pathway of macrophage activation distinct from that elicited by LPS and IFNγ.
IL4 and TGFβ can act as M2 polarizing agents, and both have been suggested to play positive roles in postinfarct repair. 14, 47 Baseline levels of the ISGs (IRF7, IFIT1, IFIT3) were reduced by treatment with these agents ( Figure 3K ). Because these ISGs are downstream targets of cGAS-mediated signaling, their response to IL4 and TGFβ suggests a role in tissue repair after ischemia. The presence or absence of cGAS had no effect on the ability of LPS and IFNγ to induce the expression of ISGs in BMDMs ( Figure 3K ).
cGAS −/− Macrophages Derived From Human THP1 Monocytes Express Higher Levels of M2 Markers and Produce Larger Amounts of Fibronectin
To determine whether a similar pathway of cGASmediated signaling occurs in human macrophages, we used THP1 cells, a human monocyte cell line used ex-
Figure 2. No impact of silencing of GMP-AMP synthase (cGAS)-mediated signaling on the major inflammatory responses after myocardial infarction (MI).

Wild-type (WT) and cGAS
−/− mice were subjected to left anterior descending artery ligation. Three and 7 days after surgery, ventricular tissue was collected from infarct and remote areas, and RNA was harvested. Quantitative real-time polymerase chain reaction was performed with primers for Another characteristic of the M2-like macrophage phenotype is increased production of fibronectin. 48, 53 A ligand of integrins αvβ3 and α5β1, fibronectin is enriched in the provisional matrix after MI 54, 55 and promotes cell adhesion and myofibroblast differentiation, 56 a process central to myocardial wound healing. 57 To characterize further potential differences between THP1 WT and THP1 cGAS −/− cells, we examined fibronectin production in response to IFNγ, a classic stimulus that polarizes macrophages to M1-like subtype, 53 and TGFβ and IL4, cues that elicit M2-like changes. 53 We were unable to use both IFNγ and LPS simultaneously for M1 polarization because of the induction of cell death in THP1 cGAS −/− cells. THP1 cells manifested increased fibronectin expression in response to IL4 and 
ORIGINAL RESEARCH ARTICLE
IL13, 48 the 2 classic cytokines used to polarize macrophages toward an M2-like phenotype, 53 and are thus classified as M2 markers. 53 THP1 cGAS −/− macrophages produced markedly more baseline fibronectin, measured as the amount of fibronectin from total cellular protein samples and the amount secreted into the culture medium ( Figure IIG and IIH in the online-only Data Supplement). When stimulated with IFNγ, fibronectin levels decreased significantly in THP1 cGAS −/− cells, consistent with polarization toward the M1-like subtype ( Figure IIG and IIH in the online-only Data Supplement). Regardless, THP1 cGAS −/− cells continued to produce significantly more fibronectin compared with WT ( Figure IIG and IIH in the online-only Data Supplement). TGFβ and IL4 treatment elicited an increase in fibronectin production in WT THP1 cells but had no discernible impact in THP1 cGAS −/− cells ( Figure IIG and IIH in the online-only Data Supplement), suggesting that maximal production of fibronectin was present already. The inflammatory cytokine IL6, a marker of M1-like macrophages, 53 secreted into the medium in response to IFNγ by cGAS −/− THP1 cells was significantly lower than that from WT THP1 ( Figure IIG and II I in the online-only Data Supplement).
Next, we investigated whether macrophages lacking cGAS can promote extracellular matrix protein synthesis in fibroblasts. Murine fibroblasts were cocultured with WT or cGAS −/− macrophages derived from THP1 cells. After 48 hours of incubation, the fibroblasts were washed and collected, and protein extracts were prepared for immunoblot analysis. We found that the steady-state levels of fibronectin were significantly increased when fibroblasts were cocultured with cGAS 
Loss of cGAS Signaling Increases the Abundance of Reparative Macrophages
Evidence presented so far suggests that loss of cGAS signaling promotes the emergence of reparative M2-like subtype macrophages. To test this in the setting of myocardial ischemia, transverse sections of hearts 6 days after MI were stained for CD68 and CD206, cell surface markers commonly used to label total macrophages and the reparative M2-like subtype, respectively. WT and cGAS −/− hearts harbored comparable numbers of total macrophages in the infarct region ( Figure 4A ). However, CD68 + CD206
+ macrophages were more prominent in the hearts of cGAS −/− mice, suggesting that there are more reparative macrophages in the mutant animals ( Figure 4A ).
To further characterize the macrophage population after MI in WT and cGAS-null mice, we isolated immune cells from the infarct area and performed fluorescence-activated cell sorting analysis. Cells were labeled with surface markers that differentiate them into myeloid cells, neutrophils, and macrophages/monocytes on the basis of established gating strategies. 10 ure 4B and 4D ), consistent with a more abundant M2-like population. We observed no significant differences in the number of total macrophages at post-MI day 3 after adjusting for the volume of infarct tissue, suggesting that cGAS does not play a major role in maintaining the total population of macrophages at this time point. In aggregate, complementary data collected from both immunohistochemistry and fluorescence-activated cell sorting analyses demonstrate that cGAS silencing results in significantly more abundant reparative macrophages in the infarct zone of the left ventricle (LV).
Loss of cGAS Signaling Facilitates Myocardial Wound Repair by Promoting Myofibroblast Transformation and Angiogenesis
Reparative macrophages have been suggested to promote wound healing in hearts damaged by myocardial ischemia, although the exact mechanism is not well defined. 10, 13, 14, 59 Efficient repair depends on the transformation of fibroblasts into myofibroblasts, which produce copious amounts of extracellular matrix protein and facilitate wound contraction, 60 processes essential in building replacement tissue with high tensile strength to prevent infarct expansion and rupture. To determine 
Wild-type (WT) and cGAS
−/− mice were subjected to left anterior descending artery ligation. Six to 7 days after surgery, hearts were perfusion fixed with 4% paraformaldehyde followed by cryosectioning at levels described in Methods. Alternatively, immune cells were isolated for fluorescence-activated cell sorting (FACS) analysis. Scale bar: 100 µm. A, Heart sections colabeled with CD68, a marker of total macrophages, and CD206, a marker of M2-like macrophages. the impact of cGAS silencing on fibroblast differentiation after cardiac ischemic injury, we performed immunohistochemical staining for α-smooth muscle actin ( Figure 4E ), a commonly used marker of myofibroblasts. 61 We detected significantly stronger and more extensive α-smooth muscle actin staining in the infarct border and central areas of cGAS −/− compared with WT hearts (Figure 4E ), suggesting that myofibroblasts are more prevalent in knockout hearts during the process of myocardial wound repair.
Macrophages and specifically M2-like macrophages play key roles in promoting angiogenesis in tumors.
62,63
Thus, we next tested for effects of the observed M2-like cells switch on neovascularization in WT and cGAS-null mice after MI, labeling heart sections with CD31, an endothelial cell surface marker. At baseline, vascularization was similar in WT and cGAS-null hearts ( Figure IV in the online-only Data Supplement). However, in heart tissue after MI, we detected remarkably more microvasculature in cGAS-null mouse hearts after MI compared with WT hearts ( Figure 4F ). This difference was most apparent in the border and center regions, with no significant differences seen in the remote region. In aggregate, these results support a model in which cGAS-mediated signaling Figure 4 Continued. E, MI hearts obtained from WT and cGAS −/− mice were stained with anti-α-smooth muscle actin antibody (αSMA). Images are from different areas of the infarct. F, Heart cryosections obtained from WT and cGAS-null mice were stained for the endothelial marker CD31. Images were acquired from the infarct center, infarct border, and remote areas. A cohort of 4 to 6 animals from WT or cGAS-null mice was evaluated. Box-and-whisker plots: the box extends from the 25th to 75th percentiles; whiskers depict minimal to maximal values; the mean is indicated with a plus sign. DAPI indicates 4',6-diamidino-2-phenylindole. *P<0.05. **P<0.01. ***P<0.001. 
Inactivation of cGAS Diminishes Pathological Ventricular Remodeling After MI and Improves Survival
Findings reported thus far demonstrate that cGASdependent sensing of cytosolic DNA promotes a phenotypic shift toward the inflammatory, M1-like macrophage subtype. In the absence of cGAS, phenotypically M2-like cells predominate, promoting wound-healing phenotypes such as enhanced fibrogenesis and angiogenesis. Given this, we postulated that loss of cGAS signaling would blunt pathological remodeling in the setting of MI. After confirming that the areas at risk of infarction were comparable in the 2 genotypes ( Figure  V in the online-only Data Supplement), we subjected WT and cGAS-null mice to MI and evaluated a panel of molecular, morphological, and functional parameters over a time span of 3 days (acute), 2 weeks (subacute), and 3 months (chronic). First, transverse sections of the LV were evaluated at the level of left anterior descending artery ligation and 0.5, 1.0, 1.5, 2.0, and 2.5 mm below the ligation ( Figure 5A and 5B).
We first observed that chamber dilation and infarct expansion were significantly attenuated in cGAS −/− hearts. Gravimetric analyses revealed that heart weight normalized to body weight or tibia length was greater in WT animals than in cGAS −/− mice ( Figure 5C and 5D). We observed statistically significant differences as early as 3 days after MI, the earliest time point studied, and those differences persisted at 7 and 14 days. Geometric remodeling index (LV cavity area divided by the thickness of the septum), an index of LV geometry, manifested wide separation between WT and cGAS −/− mice ( Figure 5E ). The progressive increase in geometric remodeling index toward the apex is consistent with greater chamber enlargement distal to the left anterior descending artery ligation in WT animals because of infarct expansion. Notably, this progressive increase in geometric remodeling index was not observed in cGAS knockout mice, suggesting diminished infarct expansion and less LV dilatation.
Cardiac mass continued to increase during the chronic remodeling phase in WT mice (12 weeks after MI), but this trend was blunted in cGAS knockout animals ( Figure 5F ). Furthermore, whereas baseline echocardiographic parameters were comparable in WT and cGAS-null mice (Table 1) , contractile function measured 10 weeks after MI was significantly improved in cGAS knockout compared with WT hearts ( Figure 5G) .
To characterize the remodeling process further, we evaluated activation of the fetal gene program after MI in WT and cGAS knockout mice. We noted that these markers of pathological ventricular remodeling were significantly lower in cGAS knockout hearts (Figure 5H-5K) .
To determine whether cGAS deficiency affects infarct size, we used the midline method as described previously. 64 The percentage of scar length to LV circumference drawn midway between epicardial and endocardial surfaces is a validated measure of infarct size, one that is more accurate than scar area owing to scar thinning, which can lead to underestimation of infarct size. 64 When comparing infarct sizes on serial LV crosssections, we observed a modest decrease in infarct size in cGAS-null mice, especially at the basal sections (Figure 5L) . Remarkably, however, silencing of cGAS led to robust improvement in post-MI survival ( Figure 5M ): mortality within 1 week of MI was 42% (15 of 35) in WT, comparable to the 25% to 42% mortality reported in the literature.
14 Mortality in cGAS-null mice, however, was 3% (P<0.001; Figure 5M ).
Postmortem examination revealed that the major cause of post-MI mortality was free wall rupture, as illustrated in a section from a WT mouse ( Figure 5N ), followed by heart failure. Again, these relative proportions leading to death are consistent with those reported in the literature.
14 Our finding of low mortality in cGASnull mice is consistent with improved myocardial wound healing leading to the formation of replacement tissue with greater tensile strength. Equally or more important, inadequate repair imposes greater hemodynamic stress on the remaining normal myocardium and exacerbates the remodeling that occurs acutely within 1 week of MI. 65 Collectively, our data are consistent with a model in which the cGAS-mediated cytosolic DNA sensing pathway inhibits postinfarction repair, and the major benefit accrued from loss of cGAS signaling stems from improvements in tissue integrity and diminished remodeling, beginning early in the acute stage and lasting well into the chronic phase.
Blocking cGAS-Mediated DNA Sensing Improves Myocardial Repair After Infarction
To define mechanisms underlying the robust improvement in cardiac structure and function after MI in cGAS-null animals, we tested for evidence of enhanced postinjury repair. First, we assessed the infarct region for collagen deposition. Hematoxylin-eosin staining 1 week after MI at the border and central regions of the infarct revealed that general cellular infiltration was similar in WT and cGAS-null hearts ( Figure 6A ). However, the infarct region in cGAS −/− mice at both areas was denser with more compact architecture compared with WT animals. We then analyzed collagen content using 
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Masson Trichrome staining, Picrosirius red staining, and polarized light. Trichrome staining and Picrosirius red staining are standard methods used to quantify collagen content in tissues, 14, 66, 67 and polarized light detects the natural birefringence of collagen and provides additional information regarding collagen fiber structure, order, thickness, and packing. 66, 68 Both Trichrome staining and Picrosirius red staining revealed denser collagen deposition in cGAS −/− hearts ( Figure 6B ). Under polarized light, collagen was detected in a tightly packed, multimolecular microfibrillar form in cGAS knockouts, whereas it appeared as single fibers in WT animals To directly compare the amount of collagen localized within the ischemic region, we purified soluble and insoluble collagen from WT and cGAS-null mice 1 week 
after MI and quantified collagen levels. We found a significantly greater abundance of soluble collagen in the provisional matrix in cGAS-null mice, whereas the insoluble fraction of collagen was comparable between WT and cGAS-mutant mice ( Figure 6F ). Because insoluble collagen is extensively cross-linked, these data suggest that the collagen in cGAS-null mice after MI has not yet cross-linked extensively, consistent with the early stage of repair at 1 week. Nonetheless, these results support the notion that cGAS silencing leads to a higher collagen concentration in the infarct region. The presence of dense granular tissue, higher density collagen, and more collagen fibrils suggests that tensile strength from the healing tissue in cGAS knockout animal hearts is greater than that in WT. To test the notion that hemodynamic stress in the remote region of the ventricle was mitigated in cGAS −/− hearts, we compared collagen 1 and fibronectin levels from remote tissue areas after MI ( Figure 6G and 6H). Collagen 1 content was significantly greater in the remote area of WT hearts than in a similar area in cGAS −/− hearts 3 days after MI. At the same time point, fibronectin levels were also more abundant in WT hearts than in cGAS −/− hearts. Increases in collagen 1 subsided after 1 week, whereas fibronectin remained elevated in WT but not cGAS −/− hearts ( Figure 6I and 6J). As the major extracellular matrix proteins, increases in collagen 1 and fibronectin represent immediate extracellular matrix expansion in the noninfarct area, a phenomenon also observed clinically after MI. 65 Because the increase in extracellular matrix content is a sequela of hemodynamic stress and systolic dysfunction, reduced collagen 1 and fibronectin levels in cGAS −/− mice suggest more favorable hemodynamics and better systolic performance in the noninfarcted myocardium. In aggregate, these findings point consistently to enhanced tissue repair after ischemic damage in cGAS-null mice.
Evidence of cGAS-STING Pathway Activation in Human Heart Failure Samples
Finally, to begin to evaluate the relevance of these findings in human disease, we tested for activation of the cGAS-STING pathway in human heart failure secondary to ischemic heart disease. We obtained heart tissues from both failing and nonfailing hearts from the Duke Human Heart Repository (baseline clinical characteristics are provided in Table 2 ). RNA was harvested from normal control hearts, from failing hearts at the time of LV assist device (LVAD) implantation, and from the same patients after LVAD implantation at the time of heart transplantation surgery. Consistent with our findings in mice, dynamic changes in the abundance of cGAS and its target CXCL10 transcripts were seen before and after LV unloading ( Figure 7A and 7B) , suggesting strongly that this pathway is active in clinical heart failure in patients.
DISCUSSION
Inflammatory mechanisms play a central role in the response to myocardial ischemic injury. Cell injury triggers the release of DAMPs, which bind to PRRs, triggering inflammatory responses. The sterile inflammation that ensues is critical to the repair of the initial insult. However, overheated inflammation eventually leads to cGAS indicates cyclic GMP-AMP synthase; EF, ejection fraction; FS, fractional shortening; HR, heart rate; ID, identification; IVSd, interventricular septum at end diastole; IVSs, interventricular septum at end systole; LVIDd, left ventricular internal diameter at end diastole; LVIDs, left ventricular internal diameter at end systole; LVM, left ventricular mass; LVPWd, left ventricular posterior wall at end diastole; LVPWs, left ventricular posterior wall at end systole; and WT, wild-type. 
Wild-type (WT) and cGAS
−/− mice were subjected to left anterior descending artery ligation. One week after the procedure, hearts were harvested and fixed. Transverse sections were processed to obtain the following images. Insets are color-coded with corresponding high-magnification images. Scale bar: 100 µm throughout. A, Hematoxylin-eosin staining. B, Trichrome (TC) or Picrosirius red (PSR) staining to detect collagen. Polarized light (PL) was used to examine collagen fiber structure. C through E, Collagen density quantified as the area of collagen divided by total area examined. (Continued ) disease. Among the mechanisms leading to resolution of injury, macrophage-dependent clearance of necrotic tissue followed by tissue repair is vital, 10, 13, 14, 69 and macrophage transformation from inflammatory cells to a reparative phenotype is the prerequisite for tissue healing. However, the environmental cues and mechanisms governing the shift from the destructive M1-like macrophage phenotype to the reparative M2-like subtype have remained obscure. Here, we explored the role of a recently described innate immune pathway of cytosolic DNA sensing. We report that the cytosolic DNA sensor cGAS is activated robustly in the setting of MI, triggering downstream events mediated by the STING cascade. This, in turn, sustains the inflammatory M1-like macrophage phenotype. Inactivation of this pathway promotes transformation toward the M2-like macrophage subtype, facilitating wound healing; angiogenesis; diminished pathological cardiac remodeling, including ventricular rupture; and markedly enhanced survival after MI. Together, these findings point to cGAS as a PRR for ischemic injury and uncover a novel mechanism that governs macrophage phenotypic switching and postinfarction remodeling.
Post-MI Ventricular Remodeling
The tissue wound stemming from MI is most vulnerable between days 2 and 7 after MI, when tissue destruction is robust and only granular tissue, but not scar with a high content of mature collagen, is present. This leaves the LV free wall prone to rupture and, as a result of the compromised capacity to generate tension, progressive thinning of the infarct region and increased hemodynamic stress in remote tissue zones. In fact, in murine MI models, rupture is the predominant cause of death. 70 Cardiac rupture, although less common in patients with MI currently, remains an important concern, accounting for 12.4% of deaths in patients enrolled in Figure 6 Continued. F. Quantification of soluble and insoluble collagen purified from the infarct tissue at 1 week after myocardial infarction (MI). G and H, Collagen (Col1) and fibronectin (Fn) proteins from the remote zone of myocardium as indicators of ECM expansion, a reflection of hemodynamic strain within those regions of ventricle. I and J, Summary data. n=4 to 10. Box-and-whisker plots: the box extends from the 25th to 75th percentiles; whiskers depict minimal to maximal values; the mean is indicated with a plus sign.*P<0.05. **P<0.01. ***P<0.001.
the VALIANT trial (Valsartan in Acute Myocardial Infarction) published in 2010. 71 Ischemic injury of the myocardium triggers a complex cascade of events involving clearance of necrotic tissue, deposition of extracellular matrix elements, and tissue repair. 3 The extent of the initial infarction and effectiveness of the repair process after this event combine to dictate long-term ramifications on heart function. Clinically, limiting infarct size by timely reperfusion of the occluded coronary artery is the most immediate and effective treatment. However, therapeutic targeting to promote the repair process has potential for meaningful improvement in clinical outcomes by limiting adverse remodeling and preserving function of the remaining myocardium.
A robust inflammatory response and inefficient repair are driving forces of remodeling and heart failure. [4] [5] [6] [7] 72 However, to date, the ability to manipulate this response therapeutically has proved challenging. Indeed, optimal repair requires a delicate balance of tissue destruction and scar formation, neovascularization, and wound healing. In this study, we have uncovered an important role for the cytosolic DNA sensing pathway cGAS-STING during myocardial repair after ischemic injury.
Macrophage Differentiation and Myocardial Repair After Ischemic Injury
Depending on the context, macrophages can either promote inflammation and progression of tissue injury or improve wound healing and tissue remodeling. 1 This duality of function derives from the unique ability of macrophages to exist in a continuum of activation states. The crucial role of monocyte/macrophage transformation from inflammatory to reparative phenotype in post-MI repair has been demonstrated recently. 14 Mice harboring macrophages with impaired ability to transform into reparative macrophages (secondary to deletion of the Trb1 kinase) manifest a dramatic increase in mortality and ventricular rupture after MI compared with WT animals.
14 Here, we report that infarcted hearts in mice lacking cGAS manifest no obvious declines in total macrophage infiltration yet harbor decreased numbers of proinflammatory (M1-like) macrophages with a shift toward CD206-positive, reparative (M2-like) cells. This shift in monocyte/macrophage pools results in a dramatic decrease in post-MI cardiac rupture and associated mortality.
Changes in the microenvironment that dictate macrophage transformation are poorly understood. Findings reported here point to cytosolic DNA sensing by the cGAS pathway as an important and previously unrecognized driver of the expression of inflammatory macrophage phenotypes. Indeed, cytosolic DNA induced iNOS and CXCL10, key features of inflammatory macrophages, in a cGAS-dependent manner in BMDMs. Remarkably, we found that the ischemiainduced expression of CXCL10 depended entirely on an intact cGAS pathway. Our findings are consistent with a model in which biasing macrophages toward the 
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reparative subtype by inactivation of the cGAS-STING pathway promotes myocardial tissue repair ( Figure 8 ).
We report that without cGAS-mediated signaling, macrophages derived from both BMDMs and human THP1 monocytes express lower levels of M1 markers such as CXCL10 and higher levels of markers of the M2 subtype such as CD163 and fibronectin (Figure 3 and Figure  I in the online-only Data Supplement). 48 However, these cells can still be biased toward the M1-like phenotype when exposed to stimulators of the microbial inflammatory response such as LPS. In our in vivo model of MI, loss of cGAS promotes accumulation of macrophages strongly positive for CD206 (M2 marker) within the infarct area. Because the functional transformation of macrophages (toward or away from M1-like or M2-like states) involves hundreds of genes, 39 loss of cGAS and the ensuing dampened IRF3 response are likely upstream triggers that orchestrate a complex cascade of events. In fact, our findings that cGAS downstream targets are among the most downregulated genes observed in M2-like macrophages 39 support a model in which cGAS-mediated cytosolic DNA sensing is crucial in influencing macrophage phenotype during myocardial repair after ischemic injury. However, it is important to emphasize that the M1/M2 dichotomy classification is a useful oversimplification of a broad functional spectrum, one in which M1-like and M2-like macrophages occupy opposite extremes and yet a functional continuum exists in between. Whereas we observed meaningful changes in macrophage behavior, overall inflammatory cytokine at transcript levels were not altered significantly in the infarcted cGAS-null heart compared with the WT heart. However, specific ISGs such as Cxcl10, IRF7, IFIT1, and IFIT3 are expressed in ischemic hearts in a cGAS-dependent manner. Indeed, ISG expression is reduced in macrophages treated with IL4 or TGFβ. These anti-inflammatory cytokines, which can polarize macrophages to the M2-like subtype, have been shown to play important roles in tissue repair remodeling after infarction.
Perhaps the most direct impact on myocardial wound repair of the shift in macrophage phenotype stemming from loss of cGAS is the greater amount of fibronectin produced. Fibronectin is a major component of the provisional matrix after MI to which fibroblasts migrate and proliferate and where they differentiate into myofibroblasts. 73 Thus, fibronectin expression is pivotal in myocardial wound healing. Indeed, our analysis of the MI repair response is consistent with enhanced repair in cGAS −/− hearts. MI is often marked by infarct expansion, disproportionate wall thinning, and dilatation of the infarct segment, which confer meaningful clinical consequences. 72 Infarct expansion gives rise to additional LV dilatation and consequent enhanced stress to remote functioning myocardium. Not surprisingly, patients with expansion of an infarct have diminished exercise tolerance, more heart failure symptoms, and greater early and late mortality than those without expansion. 72 Adequate myofibroblast density limits infarct expansion by promoting deposition of strong and flexible replacement tissue. 74 Indeed, numerous lines of evidence point to malformed scar and a high incidence of cardiac rupture when there are defects in fibroblast adhesion, recruitment, and transformation. 75 We show here that inactivation of cGAS promotes M2-like macrophage transformation, diminished LV dilatation, and suppressed infarct expansion. The reparative granular tissue in cGAS −/− mice harbors a greater number of myofibroblasts, which contribute to greater collagen density and cross-linked collagen fibrils, which together afford more tensile strength to the tissue. The ultimate consequence is decreased risk of ventricular rupture and improved survival despite the modest decrease in the size of the original infarct. In addition, the infarct size analysis is confounded by the high mortality rate observed in WT animals.
We also observed enhanced angiogenesis after MI in cGAS-null hearts. As new blood vessel formation Ischemic injury activates cGAS-mediated signaling, possibly through detection and binding of nuclear DNA and mitochondrial DNA released from necrotic myocardium. cGAS activation promotes tissue destruction by sustaining proinflammatory macrophages (Mφ) (M1-like). Excessive tissue destruction leads to cardiac rupture, progressive remodeling, and heart failure. cGAS silencing promotes macrophage transformation toward a reparative (M2-like) phenotype that fosters efficient repair, mitigates adverse remodeling, and improves cardiac function.
provides nutrients and supports the provisional matrix and peri-infarct area, effective angiogenesis leads to enhanced myocardial perfusion, a reduction in infarct size, and enhanced survival. 76 
cGAS-Mediated Signaling and the Inflammatory Response After MI
A prior study suggested a role for cGAS in constitutive production of basal levels of IFNs and ISGs 26 in macrophages through tonic signaling, 77 which may help to explain the fundamental differences in phenotypes between WT and cGAS −/− cells at baseline and after DNA stimulation. The cGAS −/− macrophage has a signature profile more consistent with that of M2-like macrophages, although they cannot be strictly defined as M2-like macrophages, a nomenclature assigned to cells after they are stimulated with anti-inflammatory cytokines such as IL4 and IL13. 53 Moreover, unlike our in vivo findings that showed that loss of cGAS did not influence the major inflammatory cytokines at the transcript level, cGAS loss of function in THP1 cells resulted in higher levels of IL1β at baseline and after DNA stimulation (data not shown), highlighting the complexity of macrophage polarization. M1-like and M2-like macrophages are known to generate (at least) comparable levels of inflammatory cytokines in the heart after MI. 37 The beneficial impact of cGAS inactivation does not derive from alterations in major elements of the inflammatory cytokine system, including IL1β, IL18, IL6, and TNFα transcripts, suggesting that myocardial repair can be fostered without interference with pathways mediated by these cytokines. A robust inflammatory response after MI is essential to remove damaged myocardium. However, prolonged and robust inflammation is associated with worse outcomes. [5] [6] [7] Although proinflammatory cytokines are known to promote tissue destruction and are thought to be responsible for a negative impact on wound healing, they are also profoundly pleiotropic. 78 This pleiotropy is a difficult obstacle to overcome when the aim is to neutralize, antagonize, and block the cytokines. 79 Among many examples, studies have shown that sustained expression of TNFα contributes to the development of heart failure; however, TNFα can also exert cytoprotective effects in a desmin-deficient heart failure model in mice. 80 Moreover, loss of signaling in mice depleted of IL1R1, the only signaling receptor for IL1, not only attenuated the recruitment of inflammatory monocytes/macrophages but also diminished accumulation of the reparative macrophage subtype. 33 Our results indicate that targeting cGAS may achieve better outcomes without perturbing the intricate and pleiotropic cytokine system. It is also important to emphasize that we examined these cytokines at the level of transcript only. Additional studies are necessary to determine the involvement of these important inflammatory pathways.
DNA as a Danger Signal in MI
DNA is normally sequestered within the nucleus and mitochondria, away from the cytosol. cGAS, a recently discovered mechanism of the innate immune response, is the predominant sensor of double-stranded DNA in the cytosol. 18, 19 cGAS recognizes the sugar-phosphate backbone in DNA; hence, the binding between DNA and cGAS is sequence nonspecific. Toll-like receptor 9 (TLR9) is also known to recognize DNA inside the cell. However, it is located within the endosome with its binding domain facing the lumen. 45 TLR9 preferentially binds DNA harboring unmethylated CpG motifs that are prevalent in microbial DNA but much less common in vertebrate genomic DNA. 81 TLR9 has been suggested to mediate the inflammatory response in a heart failure model generated from pressure overload by recognizing mitochondrial DNA. 82 However, increased incidence of cardiac rupture after MI in TLR9-null mice was observed with no impact on remodeling and cardiac function. 83 In addition, the overall inflammatory responses were comparable between WT and TLR9-null mice after MI. 83 It is intriguing that loss of DNA sensing in the cytosol (cGAS inactivation) and loss of CpG DNA recognition inside the endosome (TLR9 inactivation) led to opposite results in terms of maintenance of cardiac tissue integrity. However, we suggest that cGAS-specific effects on macrophage transformation may hold the key. 83, 84 Unlike cGAS, TLR9-mediated signaling is unable to activate IRF3, 85 which is a crucial point in sustaining proinflammatory macrophages. 86 In addition, differences in the primary cell types in which each specific pathway operates may contribute. Indeed, some evidence suggests that fibroblasts are the primary cell type affected by TLR9 signaling.
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Future Directions and Perspective
Our findings raise a number of intriguing questions. First, the current standard of care for patients with acute coronary occlusion is reperfusion therapy; hence, determining the impact of cGAS-STING in a model of ischemia/reperfusion injury will be of interest. Whereas reperfusion blunts injury and infarct size, it also evokes damage of its own that contributes to final infarct injury, and it will be intriguing to evaluate this pathway in that context. Second, evidence suggests that inflammation is a prominent feature in the chronic remodeling phase after MI, 87 and elucidation of this pathway in this phase of the process will be informative. Third, it is known that cardiac-resident macrophages and those derived from peripheral circulating monocytes have different functions. 58 Delineation of the contributions of distinct groups of macrophages will help to differentiate the impact of cGAS in maintaining homeostasis and after stress. Finally, although it is clear that silencing cGAS in the entire or-ganism is protective in MI, whether the phenotype derives exclusively from monocyte/macrophage-specific cGAS function is unknown because activation of the pathway in other cell types might conceivably contribute to the overall benefit.
CONCLUSIONS
This report identifies cytosolic DNA sensing mediated by cGAS as a novel PRR in myocardial ischemic injury and unveils its important role in governing macrophage function during repair of the damaged heart. Inhibition of this pathway protects the heart by improving early survival, inhibiting pathological remodeling, promoting angiogenesis, and preserving cardiac function. The underlying mechanism is that loss of cGAS improves the repair process by priming macrophages toward a reparative phenotype. Furthermore, our findings provide insight into the microenvironmental cues and mechanisms controlling the transition of proinflammatory macrophages to a reparative subtype that could serve as potential targets for future novel interventions aimed at macrophage transformation.
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